Prior to the analysis of the device, the quality documents accompanying the manufacturing process for this pacemaker were re-investigated.All production steps were performed accordingly, and in particular the final acceptance test proved the device functions to be as specified.Next, the pacemaker was subjected to an electrical analysis, revealing that the device could not be properly interrogated, confirming the clinical observation.The inspection of the devices memory showed a severe invalid memory content.The ability of the device to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be normal.The device operated in vvi mode with 50 bpm and 4.8 v at 1.0 ms.There was no indication of a device malfunction.During the further course of the analysis, the device was opened and the inner assembly was inspected.The visual inspection of the inner assembly showed no anomalies.The battery was found almost depleted.The electronic module was attached to an external power supply to test the functionality of the module.Thereby, the electrical parameters, particularly the current consumption of the electronic module were found to be normal and as expected.All therapy functions were available and worked as expected in the safety backup mode.Subsequently, using a technical programming tool, the device was reset showing a proper device functionality.The battery was sent to the manufacturer for further detailed analysis.The analysis is still ongoing.Should relevant information become available, the investigation will be updated.
|